Science Explorer Back to mapMap
Discussion
Researcher · Bayer (Germany) · Germany

Ningshu Liu

Ningshu Liu publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as PI3K/AKT/mTOR signaling in cancer, Chronic Lymphocytic Leukemia Research and Cancer, Hypoxia, and Metabolism.

OpenAlex
World rank
#603,355
of 7,710,434 ranked researchers
Rank in Germany
#29,689
of 364,343
Works
90
Citations
2k
Citations per work
21.8
h-index
17
i10-index 20Top 42% in Molecular Biology
Ningshu Liu

What does Ningshu Liu research?

Ningshu Liu's work is mostly in Biochemistry, Genetics and Molecular Biology (39%), Medicine (30%), Immunology and Microbiology (9%).

Life Sciences: 43 works · 47.6% of their workBiochemistry, Genetics and Molecular Biology: 35 works · 38.8% of their workMolecular Biology: 26 works · 29.4% of their workCancer Research: 8 works · 9.4% of their workImmunology and Microbiology: 8 works · 8.8% of their workImmunology: 8 works · 8.8% of their workHealth Sciences: 27 works · 30.0% of their workMedicine: 27 works · 30.0% of their workOncology: 11 works · 12.5% of their workPulmonary and Respiratory Medicine: 10 works · 10.6% of their workGenetics: 6 works · 6.9% of their workEverything else: 20 works · 22.4% of their workTHEIR WORKNingshu Liu90works
Life Sciences48%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3538.8%
    2. Immunology and Microbiology88.8%
    1. Medicine2730.0%
  3. Everything else2022.4%
  1. 1Molecular Biology29% of their works
  2. 2Oncology12% of their works
  3. 3Pulmonary and Respiratory Medicine11% of their works
  4. 4Cancer Research9% of their works
  5. 5Immunology9% of their works
  6. 6Genetics7% of their works

Research topics

Which keywords describe Ningshu Liu's research?

The keywords of their largest research topics: mTOR, Signaling, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, HIF-1, Warburg Effect and Breast Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Signaling231 topic
  2. mTOR231 topic
  3. Rituximab182 topics
  4. Chronic Lymphocytic Leukemia111 topic
  5. Genomic Aberrations111 topic
  6. HIF-181 topic
  7. Warburg Effect81 topic
  8. Breast Cancer71 topic
  9. CDK4/6 Inhibitors71 topic
  10. Cell Cycle71 topic
  11. Classification71 topic
  12. Lymphoma71 topic
  13. NK Cell Recognition71 topic
  14. Natural Killer Cells71 topic
  15. p5371 topic
  16. EGFR Mutations61 topic
  17. Targeted Therapy61 topic

Where does Ningshu Liu work?

Ningshu Liu's main affiliation in the publication record is Bayer (Germany), Germany.

How many publications and citations does Ningshu Liu have?

OpenAlex counts 90 works and 1,961 citations for Ningshu Liu, an h-index of 17, ranking #603,355 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ningshu Liu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.